Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
Public ClinicalTrials.gov record NCT02637960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Study identification
- NCT ID
- NCT02637960
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Vantia Ltd
- Industry
- Enrollment
- 432 participants
Conditions and interventions
Conditions
Interventions
- Fedovapagon 2 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2016
- Primary completion
- Jun 30, 2017
- Completion
- Jul 31, 2017
- Last update posted
- Oct 30, 2018
2016 – 2017
United States locations
- U.S. sites
- 48
- U.S. states
- 20
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vantia Investigative Center | Anniston | Alabama | — | — |
| Vantia Investigative Center | Goodyear | Arizona | — | — |
| Vantia Investigative Center | Lincoln | California | — | — |
| Vantia Investigative Center | Murrieta | California | — | — |
| Vantia Investigative Center | San Diego | California | — | — |
| Vantia Investigative Center | Aventura | Florida | — | — |
| Vantia Investigative Center | Bradenton | Florida | — | — |
| Vantia Investigative Center | Clearwater | Florida | — | — |
| Vantia Investigative Center | Coral Gables | Florida | — | — |
| Vantia Investigative Center | DeLand | Florida | — | — |
| Vantia Investigative Center | Hialeah | Florida | — | — |
| Vantia Investigative Center | Miami | Florida | — | — |
| Vantia Investigative Center | Ocala | Florida | — | — |
| Vantia Investigative Center | Pembroke Pines | Florida | — | — |
| Vantia Investigative Center | St. Petersburg | Florida | — | — |
| Vantia Investigative Center | Tampa | Florida | — | — |
| Vantia Investigative Center | Avon | Indiana | — | — |
| Vantia Investigative Center | Topeka | Kansas | — | — |
| Vantia Investigative Center | Wichita | Kansas | — | — |
| Vantia Investigative Center | Greenbelt | Maryland | — | — |
| Vantia Investigative Center | Missoula | Montana | — | — |
| Vantia Investigative Center | Omaha | Nebraska | — | — |
| Vantia Investigative Center | Englewood | New Jersey | — | — |
| Vantia Investigative Center | Lawrenceville | New Jersey | — | — |
| Vantia Investigative Center | Albuquerque | New Mexico | — | — |
| Vantia Investigative Center | Garden City | New York | — | — |
| Vantia Investigative Center | New York | New York | — | — |
| Vantia Investigative Center | Newburgh | New York | — | — |
| Vantia Investigative Center | Poughkeepsie | New York | — | — |
| Vantia Investigative Center | Cary | North Carolina | — | — |
| Vantia Investigative Center | Concord | North Carolina | — | — |
| Vantia Investigative Center | High Point | North Carolina | — | — |
| Vantia Investigative Center | Raleigh | North Carolina | — | — |
| Vantia Investigative Center | Wilmington | North Carolina | — | — |
| Vantia Investigative Center | Winston-Salem | North Carolina | — | — |
| Vantia Investigative Center | Akron | Ohio | — | — |
| Vantia Investigative Center | Warwick | Rhode Island | — | — |
| Vantia Investigative Center | Charleston | South Carolina | — | — |
| Vantia Investigative Center | Greer | South Carolina | — | — |
| Vantia Investigative Center | Mt. Pleasant | South Carolina | — | — |
| Vantia Investigative Center | Bristol | Tennessee | — | — |
| Vantia Investigative Center | Dallas | Texas | — | — |
| Vantia Investigative Center | Houston | Texas | — | — |
| Vantia Investigative Center | San Antonio | Texas | — | — |
| Vantia Investigative Center | Clinton | Utah | — | — |
| Vantia Investigative Center | Ogden | Utah | — | — |
| Vantia Investigative Center | Salt Lake City | Utah | — | — |
| Vantia Investigative Center | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02637960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02637960 live on ClinicalTrials.gov.